Background: [18 F]Fluorodeoxyglucose (FDG) positron emission tomography (PET) is a powerful tool for the imaging of various lymphomas. Despite its high FDG avidity, there is little data on PET in ...
Patients with locally advanced breast cancer (LABC) typically undergo staging tests at presentation. If staging does not detect metastases, treatment consists of curative intent combined modality ...
Deep learning analysis of FDG PET-CT improves survival prediction in non-metastatic breast cancer, outperforming standard staging and single modality models while supporting interpretable and ...
For patients with giant cell arteritis (GCA), a higher total vascular score (TVS) based on 18 F-fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging at diagnosis is associated with a ...
PURPOSE: Although positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose (18 F-FDG) has a major impact on the treatment of adult cancer, the reported experience with extracranial ...
Reston, VA – When developing a treatment plan for cervical cancer, it is important to be able to determine a patient's prognosis, ideally at the time of diagnosis. Existing methods to arrive at a ...
Staging locally advanced breast cancer patients with 18 F-labeled fluorodeoxyglucose (FDG) PET-CT detected more distant metastases -- and thus reduced the number of patients who received combined ...
A group of researchers led by Assistant Professor WATABE Tadashi of the Graduate School of Medicine of Osaka University achieved the stable domestic production of automatic synthesis modules for ...
We conducted a retrospective review of 181 PET scans performed in 117 nonselected consecutive patients with FL treated in our institution from 2002 to 2007. Patients who underwent PET examination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results